Skip to content

A prospective clinical study on the safety and efficacy of curcuma exosomes in the treatment of dry eye disease

A prospective clinical study on the safety and efficacy of curcuma exosomes in the treatment of dry eye disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600130996
Enrollment
Unknown
Registered
2026-08-27
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye diseases

Interventions

treatment group:Turmeric exosome eye drops, twice a day, for two weeks

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–70 years (inclusive), both genders. 2. Patients with moderate-to-severe dry eye disease meeting the diagnostic criteria of the Chinese Expert Consensus on Clinical Diagnosis and Treatment of Dry Eye (2024), including corneal damage involving two or more quadrants, and/or corneal fluorescein staining score >=5, tear break-up time (TBUT) <5 seconds, affecting both eyes. 3. Those who voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Planned ocular surgery within 6 months prior to the screening period or during the study period. 2. Pregnant or breastfeeding women. 3. Presence of fungal, viral, or bacterial keratitis or conjunctivitis, or other active ocular surface inflammation. 4. Wearing contact lenses. 5. Current ocular herpes or any other ocular infection, or a history of ocular herpes or any other ocular infection within 30 days prior to screening. 6. Ocular or periorbital allergy, etc. 7. Any other condition that, in the investigator's opinion, makes the subject unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Corneal fluorescein staining;

Secondary

MeasureTime frame
Tear factors;Tear Secretion Test;tear break-up time;Ocular Surface Disease Index;

Countries

China

Contacts

Public ContactChi Zailong

Eye Hospital, Wenzhou Medical University

zailong.chi@eye.ac.cn+86 577 88075582

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026